Autophagy promotion enhances the protective effect of Morroniside on human OA chondrocyte.


Journal

Bioscience, biotechnology, and biochemistry
ISSN: 1347-6947
Titre abrégé: Biosci Biotechnol Biochem
Pays: England
ID NLM: 9205717

Informations de publication

Date de publication:
May 2020
Historique:
pubmed: 28 1 2020
medline: 8 1 2021
entrez: 28 1 2020
Statut: ppublish

Résumé

Morroniside plays a therapeutic role in knee osteoarthritis (OA) by protecting chondrocytes. PI3K/AKT signaling is involved in the regulation of chondrocytes by Morroniside. PI3K/AKT suppresses autophagy through downstream signaling. However, the regulation of chondrocyte autophagy by Morroniside and the significance of the above effect on protecting chondrocytes aren't clear. The results showed that Morroniside inhibited the autophagiy of human OA chondrocytes. Besides, both PI3K inhibitors and mTOR inhibitors significantly reversed the autophagy reduced by Morroniside, but had no effect on the protective effect of Morroniside on chondrocytes. However, the enhanced autophagy caused by overexpression of autophagic genes enhanced the protective effect of Morroniside on chondrocytes. In conclusion, Morroniside represses the autophagy of human OA chondrocyte, which is related to PI3K/mTOR pathway. Moreover, the upregulation of autophagy further promoted the role of Morroniside in treating chondrocytes. Our data present a potential clue for the therapeutic strategies of Morroniside in treating OA.

Identifiants

pubmed: 31983285
doi: 10.1080/09168451.2020.1717925
doi:

Substances chimiques

ATG5 protein, human 0
Autophagy-Related Protein 5 0
BECN1 protein, human 0
Beclin-1 0
Glycosides 0
Protective Agents 0
morroniside 0
MTOR protein, human EC 2.7.1.1
TOR Serine-Threonine Kinases EC 2.7.11.1
ATG7 protein, human EC 6.2.1.45
Autophagy-Related Protein 7 EC 6.2.1.45

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

989-996

Auteurs

Zhanhao Xiao (Z)

Department of Orthopedics, Fuzhou Second Hospital Affiliated Xiamen University Fuzhou, Fuzhou, Fujian, China.

Jiankun Wang (J)

Department of Orthopedics, Fuzhou Second Hospital Affiliated Xiamen University Fuzhou, Fuzhou, Fujian, China.

Sunyu Chen (S)

Department of Orthopedics, Fuzhou Second Hospital Affiliated Xiamen University Fuzhou, Fuzhou, Fujian, China.

Yang Feng (Y)

Department of Orthopedics, Fuzhou Second Hospital Affiliated Xiamen University Fuzhou, Fuzhou, Fujian, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH